156 filings
Page 3 of 8
8-K
cwtpau1gxoyf
4 Aug 20
Akcea Reports Financial Results and Highlights for Second Quarter 2020
4:18pm
8-K
1544p jh3s7fu
9 Jul 20
Akcea Announces Appointment of New Chief Medical Officer
7:30am
8-K
yhjcjjn
19 Jun 20
Departure of Directors or Certain Officers
4:30pm
S-8
c3kat3
21 May 20
Registration of securities for employees
4:08pm
8-K
lxfw p7rr4u7412x4ln
18 May 20
Akcea Announces Appointment of New Chief Financial Officer
7:30am
8-K
f1a hn7516
5 May 20
Akcea Reports Financial Results and Highlights for First Quarter 2020
4:16pm
8-K
vxl61w 357idaqu8e6l
29 Apr 20
Departure of Directors or Certain Officers
4:30pm
8-K
uwugmh65
9 Apr 20
Entry into a Material Definitive Agreement
7:00am
8-K
g4o6n1 ed8rlq
24 Mar 20
Akcea Therapeutics Announces Appointment of Dr. Damien McDevitt as CEO
7:37am
8-K
j9xghd
20 Mar 20
Entry into a Material Definitive Agreement
4:18pm
8-K
fflveb61
11 Mar 20
Dr. Lisa Johnson-Pratt Joins Akcea Therapeutics as Senior Vice President, New Product Strategy
7:30am
8-K
jxl8r1npofy
4 Mar 20
Departure of Directors or Certain Officers
4:40pm
DEFA14C
sl6ilw aw1h66ac
4 Mar 20
Additional information
4:31pm
DEF 14C
ikr9jh1msni
4 Mar 20
Information statement
4:18pm
8-K
07cc8hdmkqmgpnc
25 Feb 20
Akcea Reports Financial Results and Highlights for Fourth Quarter and Year End 2019
4:16pm
8-K
9ewunhejwck8
13 Feb 20
Akcea Expands Board of Directors with Appointment of Dr. Amber Salzman
7:30am
8-K
2i5sx7fn 3909p
28 Jan 20
Akcea and Ionis report positive topline phase 2 study results of
4:31pm
8-K
v9jqzz7g65 yg9lhfa
22 Jan 20
Akcea and Ionis report positive topline Phase 2 results of AKCEA-APOCIII-LRX
7:30am